Growth Metrics

ENDRA Life Sciences (NDRA) Retained Earnings (2016 - 2021)

Historic Retained Earnings for ENDRA Life Sciences (NDRA) over the last 6 years, with Q3 2021 value amounting to -$65.6 million.

  • ENDRA Life Sciences' Retained Earnings fell 1905.77% to -$65.6 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$65.6 million, marking a year-over-year decrease of 1905.77%. This contributed to the annual value of -$57.3 million for FY2020, which is 2680.61% down from last year.
  • Per ENDRA Life Sciences' latest filing, its Retained Earnings stood at -$65.6 million for Q3 2021, which was down 1905.77% from -$62.9 million recorded in Q2 2021.
  • ENDRA Life Sciences' Retained Earnings' 5-year high stood at -$13.3 million during Q1 2017, with a 5-year trough of -$65.6 million in Q3 2021.
  • Its 5-year average for Retained Earnings is -$37.0 million, with a median of -$32.8 million in 2019.
  • As far as peak fluctuations go, ENDRA Life Sciences' Retained Earnings crashed by 6328.88% in 2019, and later plummeted by 1905.77% in 2021.
  • ENDRA Life Sciences' Retained Earnings (Quarter) stood at -$17.9 million in 2017, then plummeted by 54.74% to -$27.7 million in 2018, then tumbled by 63.29% to -$45.2 million in 2019, then dropped by 26.81% to -$57.3 million in 2020, then decreased by 14.38% to -$65.6 million in 2021.
  • Its Retained Earnings stands at -$65.6 million for Q3 2021, versus -$62.9 million for Q2 2021 and -$59.7 million for Q1 2021.